|
| Objective |
| General Provisions |
| Use of Terms |
| Scope |
| Pharmaceuticals |
| Transit and Contained Use |
| Application of the Advance Informed Agreement Procedure |
| Notification |
| Acknowledgement of Receipt of Notification |
| Decision Procedure |
| Procedure for Living Modified Organisms Intended for Direct Use as Food or Feed, Or For Processing |
| Review of Decisions |
| Simplified Procedure |
| Bilateral, Regional and Multilateral Agreements and Arrangements |
| Risk Assessment |
| Risk Management |
| Unintentional Transboundary Movements and Emergency Measures |
| Handling, Transport, Packaging and Identification |
| Competent National Authorities and National Focal Points |
| Information Sharing and the Biosafety Clearing-House |
| Confidential Information |
| Capacity-Building |
| Public Awareness and Participation |
| Non-Parties |
| Illegal Transboundary Movements |
| Socio-Economic Considerations |
| Liability and Redress |
| Financial Mechanism and Resources |
| Conference of the Parties Serving as the Meeting of the Parties to this Protocol |
| Subsidiary Bodies |
| Secretariat |
| Relationship With the Convention |
| Monitoring and Reporting |
| Compliance |
| Assessment and Review |
| Signature |
| Entry Into Force |
| Reservations |
| Withdrawal |
| Authentic Texts |
| Information required in notifications under articles 8, 10 and 13 |
| Information required concerning living modified organisms intended for direct use as food or feed, or for processing under article 11 |
| Risk Assessment |
